CONTROVERSIAL ANALYSIS OF CANNABIS RECLASSIFICATION: PERSPECTIVES IN A NARRATIVE REVIEW
DOI:
https://doi.org/10.29121/jahim.v4.i2.2024.54Keywords:
Cannabis, Marijuana, Medical Marijuana, Regularize Cannabis, Cannabinoids, Patented Cannabinoids, Recreational Cannabis, Medical CannabisAbstract [English]
Cannabis has a long and controversial tradition. A narrative review was conducted in 2024 with the aim of analyzing the discrepancies in the reclassification of cannabis for medical use and research in 2020. Indexed journals, scientific digital resources, reports from international organizations, States and expert opinions from institutions and scientists were critically examined. The results showed scientific evidence on risks and possible benefits, with a complex, biased, contradictory and inconclusive history. The damage to health and life led to its classification in an international regulatory legal framework, violated by drug trafficking and the patenting of molecules that do not meet the requirements as drugs, trivializing their abuse. After legalization, abuse, trafficking and harm increased, especially among young people. The pro-legalization environment of high-potency cannabis in a globalized world has decreased the perception of risk, even among health personnel, distorting communication. The thriving cannabis industry, with its sophisticated marketing, attracts young people. It was concluded that methodological and practical inconsistencies persist in research, weakening the international drug control regime. The benefits of reclassification are not evident; on the contrary, abuse, trafficking, physical and mental illness, indirect deaths and damage to the environment continue to increase, which could lead to the legalization of all drugs, threatening human health and survival.
References
Agirregoitia Marcos, E. (2017, January 12). Cannabis and Health: The Report of the US Academy of Sciences. CANNA Foundation. Retrieved From 2024, August 4.
Albaugh, M.D., Ottino-González, J., & Sidwell, A. (2021). Association of Cannabis Use During Adolescence with Neurodevelopment. JAMA Psychiatry. Retrieved From 2024, October 9.
Aldington, S., Harwood, M., Cox, B., Weatherall, M., Beckert, L., Hansell, A., Pritchard, A., Robinson, G., & Beasley, R. (2008). Cannabis Use and Lung Cancer Risk: A Case-Control Study. European Respiratory Journal, 31, 280-286. Retrieved From 2024, March 5. https://doi.org/10.1183/09031936.00065707
Arango, C. (2022, May 23). Psychiatry Warns of the Risks of Legalizing Medicinal Cannabis: “Consumption Quadruples the Possibility of having a Mental Disorder.” Medical Writing. Retrieved From 2022, October 8.
Arkel, T. R., Luke A. Downey, L. A., Amie C., & Hayley, A. C. (2023). Evaluation of Medicinal Cannabis and Health-Related Quality of Life. JAMA Network Open, 6(5). https://doi.org/10.1001/jamanetworkopen.2021.12522
BBC World. (2018, May 19). William Brooke O’Shaughnessy, the “Grandfather” of Cannabis Research who Introduced Marijuana to Western Medicine More Than 150 Years Ago. Retrieved From 2022, December 9.
Ben Taleb, S. (2021, August 3). They Study the Long-Term Effects of Marijuana Use Among Adolescents. Pediatrics Magazine. EuropePress. Retrieved From 2022, October 8.
Bioque, M. (2022, May 23). 50% of People Who Arrive at a Hospital with a Psychotic Condition are Cannabis Users. EuropePress. Psychiatry.com. Retrieved From 2022, October 9.
Blest-Hopley, G., Colizzi, M., Giampietro, V., & Bhattcharyya, S. (2020, August 25). Is the Adolescent Brain More Vulnerable to the Effects of Cannabis? A Narrative Review of the Evidence. Frontiers in Psychiatry. Retrieved From 2022, October 9.
Bouso, J.C. (2020). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved From 2023, December 28.
CORDIS - EU Research Results. (2023, March 6). EU-funded Study Shows Cannabis Can Damage DNA. Retrieved From 2024, March 12.
Carbonel, R. (2021, December 28). Cannabis and Pain. British Journal of Pharmacology. Retrieved From 2022, October 9.
Celso, A. (2022, March 31). Psychiatrists Defended that “There is no Type of Evidence” about Medicinal Cannabis Against Mental Disorders. EuropePress.
Center for Martian Studies. (n.d.). To Children Who Read the Golden Age. Jose Marti Portal. Retrieved From 2022, October 8.
Centers for Disease Control and Prevention (CDC). (2021, November 29). Marijuana and Public Health: Data and Statistics. Retrieved From 2022, October 8.
Chatkin, J. M., Zabert, G., Zabert, I., Chatkin, G., Jiménez-Ruiz, C. A., de Granda-Orive, J. I., Buljubasich, D., Solano Reina, S., Figueiredo, A., Ravara, S., Riesco Miranda, J. A., & Gratziou, C. (2017). Lung pathology associated with marijuana use. Archives of Bronconeumology, 53(9), 510-515. https://doi.org/10.1016/j.arbres.2017.03.019
Cheer, J. (2019, October 17). Researchers Discover a Possible Therapy to Treat the Harmful Effects of Marijuana. Nature Neuroscience. Europe Press. Retrieved From 2022, October 8.
Cheung, C. (2021, April 16). A Study Links Early Cannabis Uses with Heart Disease. Europe Press. Journal of Applied Physiology. Retrieved From 2022 October 9.
Clinical and Therapeutic Information Bulletin of the National Academy of Medicine of Mexico (ANMM). (2017). Cannabis consumption and its repercussions. 60(1), 4. Retrieved From 2024, July 5.
Conrod, P.J. (2022). Cannabis and Brain Health: What's Next for Developmental Cohort Studies? The American Journal of Psychiatry, 179(5), 317-318. Retrieved From 2022, October 9.
Convention on Psychotropic Substances (1971). Retrieved From 2023, March 3.
Coughlin, L. (2021, January 12). More Than Half of People Who Use Cannabis for Pain Experience Withdrawal, Study Finds. EuropePress. Addition Magazine. Retrieved From 2022, October 9.
Cuidate Plus. (2023, September 28). Cannabis and Risk of Heart Attack: This is What You Should Know. Retrieved From 2024, January 3.
D'Souza, D. C. (2019, December 23). Cannabis in Psychiatric Disorders. The Lancet Psychiatry, 6(12), 698-969. Retrieved from 2022, October 9.
De Janon-Quevedo, L. (2014). Medical Marijuana: Medicine or Medication? Part I. Life and Ethics, 15(2). Retrieved from 2022, September 21.
Degenhardt, L. (2019, October 31). There is no Evidence That Medical Cannabis Improves Mental Health. The Lancet Psychiatry. Europe Press. Retrieved From 2022, October 9.
Delgado-Sequera, A., Hidalgo-Figueroa, M., Barrera-Conde, M. (2021). Olfactory Neuroepithelium Cells From Cannabis Users Show Alterations in the Cytoskeleton and in Markers of Adhesion, Proliferation and Apoptosis. Molecular Neurobiology, 58, 1695-1710. Retrieved From 2022, October 8.
Deutsche, W. (2020, December 2). The UN Officially Recognizes the Medicinal Properties of Cannabis. Retrieved From 2024, January 4.
El Planteo. (2024, April 12). Death by Marijuana: Myth or Reality? Retrieved from 2024, July 2.
El Tiempo. (2022, June 23). Marijuana: these are the Countries Where it is Legal. El Tiempo. Retrieved from 2022, October 8.
Escohotado, A. (2023). Opinion on the UN Decision to Recognize The Medicinal Properties of cannabis. Retrieved From 2023, December 28.
Espinosa-Jovel, C. (2023). Cannabinoids in Epilepsy: Clinical Efficacy and Pharmacological Aspects. Neurology Magazine, 39(1), 49-55. https://doi.org/10.1016/j.nrl.2020.02.005
Europe Press. (2019, July 11). Medical Cannabis Oil with Cannabidiol and The Reduces Seizures in Children with Severe Epilepsy. Frontiers in Neurology Magazine. Retrieved From 2022, October 9.
Europe Press. (2020, September 30). Cannabis in Pregnant Women Increases the Risk of Psychopathology During Childhood, According to a Study. Retrieved From 2022, October 8.
European Monitoring Center for Drugs and Drug Addiction (EMCDDA). (2023). Cannabis: the current situation in Europe (European Drug Report 2023). Retrieved From 2024, July 4.
Ferreiros, M. L., Petrungaro, V., Copertari, P., Barabini, N., Bugna, J., Vicentin, E., & Lede, R. (2017, June 21). Cannabinoids and Epilepsy. ANMAT Regulatory Science Magazine. Ministry of Health. Presidency of the Nation. Health Technology Assessment Program. National Administration of Drugs, Foods and Medical Technology. Retrieved From 2022, October 9.
Ferrer Oliver, C., Arregui Cortes, A., Galvez Chaverri, B., Claveria Blasco, M. V., Leiva Comeras, N., & Garcia Lopez, M. E. (2024). Pain Management in the Patient: Pharmacological and Non-Pharmacological Approaches to Pain Control. Ocronos Journal, 7(5), 853. Retrieved From 2024, August 1.
Fonseca-Pedrero, E., Lucas, B., & Pérez-Albéniz, A. (2020, August 3). Attenuated Psychotic Experiences and Cannabis Use in Adolescents in the General Population. Addictions Magazine, 32(1). Retrieved From 2022, October 9.
Fontanella, C. (2021, January 21). Youth with Mood Disorders Who Use Marijuana are at Increased Risk of Death or Self-Harm. JAMA Pediatrics. Europe Press. Retrieved From 2022, October 9.
Food and Drug Administration (FDA). (2018a, June 25). Statement by FDA Commissioner Dr. Gottlieb on the Importance of Conducting Proper Research to Demonstrate Safe and Effective Medical Uses for Marijuana Active Ingredients and Compounds. Retrieved From 2024, July 3.
Food and Drug Administration (FDA). (2018b, June 25). FDA Approves First Drug Made with Marijuana-Derived Active Ingredient to Treat Rare and Severe Types of Epilepsy. Retrieved From 2024, July 3.
Food and Drug Administration (FDA). (2020, July 31). FDA Approves New Indication for Drug Containing Active Ingredient Derived From Cannabis to Treat Seizures in Rare Genetic Diseases. Retrieved From 2024, July 3.
Food and Drug Administration (FDA). (2024, July 16). FDA Regulation of Cannabis and Cannabis-derived Products, Including Cannabidiol (CBD). Retrieved From 2024, August 3.
Free Newspaper. (2022, August 8). Cannabis is the Most Widely Consumed Drug In The World, According to the UN. Presented by UNOCD. Retrieved From 2024, January 13.
Freeman, T. P., & Lorenzetti, V. (2021). A Standard Unit of THC for Reporting Cannabis and Cannabinoid Health Research. The Lancet Psychiatry, 8(11), 944-946. Retrieved From 2022, October 9.
García Henares, J. F., & de Santiago Moraga, J. (2022). Updated Scientific Evidence of Treatment with Medicinal Cannabis in Patients with Chronic Pain. Addiction. https://doi.org/10.20986/resed.2022.4024/2022
García Henares, J. F., & de Santiago Moraga, J. (2022). Updated Scientific Evidence of Medical Cannabis Treatment in Patients with Chronic Pain. Journal of the Spanish Pain Society, 29(Suppl.1), 10-13. Retrieved from 2024, January 3.
Gillespie, N. A., & Kendler, K. S. (2021, January 29). Using Genetically Informed Methods to Clarify the Nature of the Association between Cannabis Use and Schizophrenia Risk. JAMA Psychiatry. Retrieved From 2022, October 9.
Goosdeel, A. (2022, June 17). More than 22 million European Adults Who Declare Themselves to be Cannabis Users. European Drug Report 2022: Trends and News. EuropePress. Retrieved from 2022, October 9.
Graalum, D. C., Patil, S., Goldstein, A., & Raskin, D. (2019). FDA Approves Syndros, First Liquid Form of Cannabinoid Dronabinol. Med Central. Retrieved From 2024, August 3.
Guardia, J. (2020, January 29). Suffering Violence During Childhood Increases the Risk of Cannabis Use in Adolescence. EuropePress. Retrieved from 2022, October 9.
Guzmán, M. (2020). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
Gómez Ochoa, S. A. (2017). Stroke and Cannabis Use in Patients without Cardiovascular Risk Factors: Systematic Review of Clinical Cases. Neurology Journal. https://doi.org/10.1016/j.nrl.2017.09.016
Hartman, B. (2021, March 29). Why Cannabis Can Make Your Heart Race. The Cannigma. Retrieved from 2024, March 22.
Heras, H., & Giannuzzi, L. (2016). Marijuana and Adolescence. Science And Society, Argentina, November-December 26(152), 39-44.
Hurd, Y. (2021, November 18). Cannabis Use During Pregnancy Influences the Placenta and Can Affect the Subsequent Development of the Baby. Proceedings of the National Academy of Science. Europe Press. Retrieved from 2022, October 8.
Infosalus. (2020, January 17). Exposure to Cannabis During Pregnancy Negatively Impacts the Development of the Fetus. Scientific Reports. Retrieved from 2022, October 8.
Infosalus. (2022). The Legalization of Cannabis Accelerates its Daily Use and its Health-Related Impact, According to the UN. Retrieved from 2024, January 2.
International Narcotics Control Board (INCB). (1961). 1961 Single Convention on Narcotic Drugs. Retrieved from 2024, November 3.
International Narcotics Control Board (INCB). (2022a). List of Narcotic Drugs Under International Control. Retrieved from 2022.
International Narcotics Control Board (INCB). (2022b). Report of the International Narcotics Control Board for 2022. Retrieved from 2022.
IntraMed Psychiatry. (2022, July 1). Cannabis Use and Respiratory and All-Cause Morbidity and Mortality. Retrieved from 2024, January 3.
IntraMed Psychiatry. (2024, May 27). Cannabis-Related Disorders and Toxic Effects. Retrieved from 2024, July 5.
JAMA Network Open. (2019, November 27). Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open, 3(1), e1921065. https://doi.org/10.1001/jamanetworkopen.2019.21065
Jelsma, M. (2023). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
La Colina, K.P., Nemeroff, C.B., & McDonald, W. (2022). Risks and Benefits of Cannabis and Cannabinoids in Psychiatry. American Journal of Psychiatry. Retrieved From 2022, October 9.
Lajus, G. (2017). New Psychoactive Substances, Emerging Drugs. Havana Cuba: Sentinel Publishing House of Science and Technology of the Ministry of the Interior.
Lajus, G. (2018). Drugs, Addicts, Family and Society. Analysis Collection. Caracas, Venezuela: Editor of Popular Power for Communication and Information.
Lakin, R. O. (2022, may 29). Good Clinical Practice. NETWORK. US Clinical Trial Registry Results Mandate National Integration with Cannabis as Medicine (OMNI-Can). Retrieved from 2022, October 9.
Latin American Cannabis Observatory (OLCI). (2022, June 27). Cannabis Use has Increased with Legalization and Covid Lockdowns, Un Report Says. The First News Portal about cannabis and the industry. Retrieved from 2023, August 8.
Leal-Galicia P., Betancourt D, González-González A, Romo-Parra H. (2018). Brief history of marijuana in the West. Neurology, 67(4), 133-140. https://doi.org/10.33588/rn.6704.2017522
Lindsey, A.H., Freeman, T.P., Gage, S.H. (2020, August 24). Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence. JAMA Psychiatry. Retrieved from 2022, October 9.
Live Sciences. (2009, june 13). Marijuana Damages DNA, May Cause Cancer. Retrieved from 2022, March 2.
López Pelayo, H., Miquel De Montagut, L., Casajuana Kögel, C., & Balcells Oliveró, M. (2018). Post-truth about Cannabis Use: Back to Evidence-Based Medicine. Addictions Magazine, 30(4), 237-242. Retrieved from 2022 October 8.
Marcotte, T. D., Grlotti, D. J., et al. (2021). Driving Performance and Safety Perception of Cannabis Users. JAMA Psychiatry, 79(3), 201-209. Retrieved from 2022, October 9.
Martínez Caballero, C., Collado Collado, F., Rodríguez Quintosa, J., & Moya Riera, J. (2015). Pain Relief: A Universal Human Right. Journal of the Spanish Pain Society, 22(5), Madrid, Sep./Oct.
Mayo Clinic Health System. (2023, June 15). Does smoking marijuana increase the risk of lung cancer? Retrieved from 2024, March 5.
Mayo Clinic. (2022, February 4). Medical Marijuana. Mayo Clinic. Retrieved from 2024, August 2.
Medical Gazette. (2020, october 23). The Regulation of Medicinal Cannabis and the Use of New Technologies, Two Topics up for debate at the Congress of the European Pain Society. News Cannabis. Retrieved from 2022, October 8.
Meier, M. H., Avshalom, A., & Knodt, A. R. (2022, May 12). Long-Term Cannabis Use, Cognitive Reserves, and Hippocampal Volume in Midlife. American Journal of Psychiatry. Retrieved from 2022, October 9.
Menéndez R. A., & Donaire I. A. (2017) Marijuana. Possible Benefits vs. Everyday Tragedies. Academia Publishing. Havana, Cuba, 135.
Metrik, J., Stevens, A. K., & Gunn, R. L. (2022, April 28). Cannabis Use and Post-Traumatic Stress Disorder. Psychological Medicine, 52(3). Retrieved from 2022, October 9.
Mills, E. (2017). Industrial Marijuana Cultivation: How Does it Affect the Environment? Humboldt Seeds Organization. Retrieved from 2024, November 23.
Mills, E. (2021). Research on the Environmental Consequences of Marijuana Cultivation. MUNDIARIO. Retrieved from 2023, November 23.
Ministry of Health, Government Delegation for the National Plan on Drugs. (2022). Cannabis Monograph: Consumption and consequences. Spanish Observatory of Drugs and Addictions. Retrieved from 2023, December 8.
Mongan, D., Föcking, M., & Colm Healy, C. (2021). Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence. JAMA Psychiatry, 78(1), 77-90. https://doi.org/10.1001/jamapsychiatry.2020.2459
Moore, B. (2022, april 3). Babies Exposed to Cannabis in Pregnancy May Be At Risk Of Obesity and High Blood Sugar Levels. Journal of Clinical Endocrinology and Metabolism. Europe Press. Retrieved from 2022, October 8.
Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W. (2020, july 8). Cannabis Products for Adult Patients with Chronic Neuropathic Pain. Better Health. Reliable Evidence. Informed Decisions. Retrieved from 2022, October 9.
National Academy of Medicine of Mexico. (2015). Cannabis Consumption and its Repercussions (Information for the General Physician). Clinical and Therapeutic Information Bulletin, 24(3), 6-8. Retrieved from 2024, January 3.
National Library of Medicine (US). (2019, august 27). Heart attack. MedlinePlus in Spanish. Retrieved from 2023, October 9.
Negrete, J. (2020). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
Official Gazette of the National Autonomous University of Mexico [UNAM]. (2022). Drug policy cannot be limited to prohibition. Retrieved from 2022.
Official Gazette of the National Autonomous University of Mexico [UNAM]. (2022). Drug policy cannot be limited to prohibition. Retrieved from 2022.
Pan American Health Organization (PAHO). (2018). Health and Social Effects of Non-Medical Cannabis Use. Retrieved from 2024, May 5.
Pan American Health Organization (PAHO). (2021). Expanding Equitable Access to Health Services: Recommendations for the Transformation of Health Systems Towards Universal Health. Washington, D.C.: Pan American Health Organization. License: CC BY-NC-SA 3.0 IGO. Retrieved from 2024, August 1. https://doi.org/10.37774/9789275324264
Paranjpe, I. (2023). Daily Marijuana Use Increases The Risk of Heart Disease. British Medical Journal. Retrieved from 2023 November 8.
Pastor, F. P. (2022, March 14). The president of Socidrogalcohol Calls for More Research in Medicinal Cannabis: “The Evidence is very Moderate.” Europe Press. Retrieved from 2023, October 8.
Pearlson, G. D., Stevens, M. C., & D'Souza. (2021, November 9). Cannabis and Driving. Frontiers in Psychiatry. Retrieved from 2022, October 9.
Pech Puebla, D. (2024). Study on the Use Of Cannabis and its Derivatives in the Mexican population. Government of Mexico. National Commission on Mental Health and Addictions. Retrieved from 2024, August 3.
Riboulet-Zemouli, K. (2020) Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
Ruchansky, E. (2021). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
Ruiz de Pinedo, I., Muñoz, L., Agirretxea, J. A., Lopez-Bas, J. I., Carvalho, M., Steegmann, J. L., Abascal, S., & Velasco, E. (2022). The Congressional Health Commission Endorses the Regulation of Cannabis for Therapeutic Purposes. Europe Press. Retrieved from 2022, October 9.
Russo, M. A., Moro, R., Segnana, G. A., Rosendo, E., di Marzio, B., & Alí, M. (2024). Mortality Related to the Use of Psychoactive Substances, 2020. Sedronar. Argentine Drug Observatory. Retrieved from 2024, July 20.
SYNDROS. (n.d.). Syndros (dronabinol) is the First and Only FDA-approved tetrahydrocannabinol (THC) CII, a Liquid Cannabinoid Used in Adults.
Santacana, E. (2021). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
ScienceDaily. (2009, june 15). Marijuana Damages DNA, May Cause Cancer, New Test Reveals. American Chemical Society. Retrieved from 2024, March 2.
Security Research Hub. (2020). Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. FIU Digital Commons. Retrieved from 2022, October 9.
Skumlien, M., Langley, C., & Lawn, W. (2021). Apathy and Anhedonia in Adult and Adolescent Cannabis Users and Controls Before and During the COVID-19 Pandemic Lockdown. International Journal of Neuropsychopharmacology, 24(11), 859-866. Retrieved from 2022, October 9.
Smith, L. A., Azariah, F., Lavender, V. T. C., Stoner, N. S., & Bettiol, S. (2015, november 15). Medication Cannabis-Based Medicine for Nausea and Vomiting in People Treated with Cancer Chemotherapy. Cochrane. Retrieved from 2024, August 2.
Suarez, P. I., Reyes, G., & Quintero, J. M. (2018). Cannabis: from its Origins to the Present. Egle Magazine, 5(12), Third Quarter.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2021, october). Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Retrieved from 2023, December 8.
Szerman, N., Maldonado, R., van-Os, J., Volkow, N., Yuste, R., Biederman, J., Alegría, M., McGorri, P., Mcguire, P., & Swanson, J. (2019, june 28). Scientific Evidence Contradicts the Message that Attributes only Beneficial Therapeutic Properties to Cannabis and Denies the Risks to Public Health. III World Congress of the World Association on Dual Disorders (WADD). Psychiatry.com. Retrieved from 2022, October 9.
Sánchez, R. (2021, March 15). The demand for cannabis has created a giant carbon footprint. “Very Interesting” Newsletter. Retrieved from 2022, October 9.
Sánchez-Monge, M. (2021, july 24). Marijuana and Public Health. Centers for Disease Control and Prevention (CDC). Retrieved on october 9, 2022, from
Sánchez-Monge, M., & Otaduy. (2020, march 1). Cannabis is the Teenage Brain's Worst Enemy. Education and Health Center. Retrieved from 2023, October 9.
United Nations (UN News). (2022). UNODC’s World Drug Report 2022 Highlights Post-Legalization Cannabis Trends, the Environmental Impact of Illicit Drugs, and Drug Use Among Women and Young People.
United Nations (UN). (2012, July 2). Marijuana, the Most Consumed Illegal Drug. Retrieved from 2024, January 12.
United Nations (UN). (2017, July 6). Marijuana is the (illegal) drug most consumed and the least dangerous. Hemp. The Cannabis Culture Magazine. Retrieved from 2024, July 13.
United Nations (UN). (2019, march). The Risks of Cannabis Legalization, Debated in the Latest World Report on Narcotics. UN News. Global view Human stories. Law, prevention and crime. Retrieved from 2022, October 9.
United Nations (UN). (2020, December 30). The Commission on Narcotic Drugs Reclassifies the Cannabis, Although it Still Considers it Harmful. Retrieved from 2023, July 15.
United Nations (UN). (2023). The legalization of Marijuana “Seems” to Increase its Consumption and has not put an end to Illegal Markets. Retrieved from 2023, December 22.
United Nations (UN). (2024). UNODC World Drug Report 2024: Harms of the World Drug Problem Continue to Mount Amid Expansions in Drug Use and Markets. Retrieved from 2024, July 27.
United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. (1988). Retrieved from 2023, March 12.
United Nations Office on Drugs and Crime (UNODC). (1961). The Single Convention on Narcotic Drugs of 1961.
University of Cambridge, n/d). University of Cambridge. (n.d.). Impact of cannabis cultivation on atmospheric carbon capture. Free Harvest. Retrieved from 2023, November 23.
University of Colorado. (2021). The Environmental Hole of Marijuana: it Already Pollutes as Much as Coal Mining. Xataka. Retrieved from 2023, November 23.
Vargas-Murcia, J. D., Isaza-Jaramillo, S. P., & Uribe-Uribe, C. S. (2022). Risk of Ischemic Stroke in Patients Using Medical Marijuana: A Case-Control Study. Drug and Alcohol Dependence. https://doi.org/10.1016/j.drugalcdep.2022.109227
Vargas-Murcia, J. D., Isaza-Jaramillo, S. P., & Uribe-Uribe, C. S. (2023). Efficacy and Safety of Medicinal Cannabis in the Treatment of Spasticity in Patients with Multiple Sclerosis. Neurology. doi: https://doi.org/10.1016/j.neuro.2023.04.001
Velasco Orozco, V.H. (2020). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
Venero Hidalgo, L., Vázquez-Martínez, A., Aliño, M., Cano-López, I., & Villanueva-Blasco, V. J. (2022, october 27). Effects of Cannabis Use on Attention and Memory in the Adolescent Population: A Systematic Review. Spanish Journal of Public Health, 96, e202210082. Retrieved from 2024, July 3.
Verdejo-García, A. (2011). Neuropsychological Effects of Cannabis Use. Journal of Addictive Disorders, 13(3), 97-101. Retrieved from 2024, January 1.
Volkow, N. (2020). Opinion on the UN Decision to Recognize the Medicinal Properties of Cannabis. Retrieved from 2023, December 28.
World Health Organization. (WHO) (2022, January 21). Schizophrenia. Retrieved From 2024, July 3.
Yáñez, C. (2019, april 25). Medical marijuana? Chile Leads International Study in Favor of its Legalization for Medical Purposes. Third. Retrieved from 2024, January 8.
Published
How to Cite
Issue
Section
